Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golimumab vs Methotrexate in peripheral Spondyloarthritis (SPARTACUS)
NCT04435288Phase 3Active, not recruiting
- Sponsor
- Ghent University Hospital
- Start
- Aug 2020
- Primary completion
- May 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of golimumab in peripheral spondyloarthritis (pSpA), sponsored by Ghent University Hospital. Started Aug 2020; status: active, not recruiting.
02
Drugs
golimumab
03
Conditions
peripheral spondyloarthritis (pSpA)
Beyond the preview
Go deeper on NCT04435288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04435288.